New Clinical Study Casts Doubt About The Safety of Diabetes Drugs
Posted on Sep 13, 2007This article published in the New York Times discusses the findings of two recent clinical studies that studied the safety of two different diabetes drugs. Both studies were published recently in the Journal of the American Medical Association.
One study examined the risks associated with the drug Avandia. It found that the drug doubled the risks of heart failure and raised the risks of heart attack by 42 percent. These findings mirrored previous findings published in the New England Journal of Medicine concerning Avandia.
A second study found that Actos, a similar drug to Avandia, actually lowered the risks of heart attacks, strokes and death but, like Avandia, also raised risks of heart failure.